<!DOCTYPE html>
<html lang="en">

<head>
  <!-- charset meta tag -->
  <meta charset="UTF-8" />
  <!-- / charset meta tag -->
  <!-- http-equiv meta tag -->
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <!-- / http-equiv meta tag -->
  <!-- keywords meta tag -->
  <meta name="keywords" content="ALBRIOZA" />
  <!-- / keywords meta tags -->
  <!-- description meta tag -->
  <meta name="description" content="ALBRIOZA" />
  <!-- / description meta tag -->
  <!-- viewport meta tag -->
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <!-- / viewport meta tag -->
  <title>Home</title>
  <!-- bootstrap css -->
  <link rel="stylesheet" href="./content/css/bootstrap.min.css" />
  <!-- custom stylesheet -->
  <link rel="stylesheet" href="./content/css/styles.min.css" />
  <!-- / custom stylesheet -->
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
  <link rel="stylesheet" media="all" href="https://use.typekit.net/yrx1oyi.css" />
</head>
<body>
  <header>
    <div class="top-menu-links text-right">
      <span>
        <a href="javascript:void(0)" class="pl-0" data-toggle="modal" data-target="#important-safety-info">Important
          Safety Information</a>
        <a href="javascript:void(0)">Product Monograph</a>
        <a href="javascript:void(0)" class="act-support redirect-icon d-none d-lg-inline">ACT Support Program</a>
        <a href="javascript:void(0)" class="pr-0 pl-2 border-right-0"><span
            class="d-inline-block d-lg-none">FR</span><span class="d-none d-lg-inline">Français</span></a>
      </span>
    </div>
    <nav class="navbar navbar-expand-lg navbar-light ">
      <a class="navbar-brand pl-lg-0" href="javascript:void(0)"><img
          src="./content/images/style-images/albrioza-logo.png" /></a>
      <button class="navbar-toggler border-0" type="button" data-toggle="collapse" data-target="#navbarNavDropdown"
        aria-controls="navbarNavDropdown" aria-expanded="false" aria-label="Toggle navigation">
        <span class="mt-1"></span>
        <span class="mt-2"></span>
        <span class="mt-2"></span>
      </button>
      <div class="collapse navbar-collapse  d-block w-100 text-center" id="navbarNavDropdown">
        <button class="btn btn-secondary rounded-circle close-btn d-lg-none" data-toggle="collapse"
          data-target="#navbarNavDropdown">&times;</button>
        <a class="navbar-brand m-0 d-lg-none" href="javascript:void(0)"><img
            src="./content/images/style-images/albrioza-white-logo.png" /></a>
        <ul class="navbar-nav ml-auto">
          <!-- dropdown link -->
          <li class="nav-item dropdown">
            <a class="nav-link dropdown-toggle" href="javascript:void(0)" role="button" data-toggle="dropdown"
              aria-expanded="false">
              EFFICACY
            </a>
            <!-- dropdown menu -->
            <div class="dropdown-menu border-0 pb-lg-0 rounded-0">
              <a class="dropdown-item" href="javascript:void(0)">CENTAUR TRIAL</a>
              <a class="dropdown-item" href="javascript:void(0)">FUNCTION</a>
              <a class="dropdown-item" href="javascript:void(0)">ABOUT ALSFRS-R</a>
            </div>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">SAFETY PROFILE</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">MECHANISM OF ACTION</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">DOSING & ADMIN</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">MANAGING EXPECTATIONS</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="javascript:void(0)">SUPPORT & RESOURCES</a>
          </li>
        </ul>
        <p class="text-white mb-0 d-lg-none">Get patients started today</p>
        <a class="nav-link btn btn-secondary position-relative d-lg-none download-icon" href="javascript:void(0)">Download enrolment
          Form</a>
        <a href="javascript:void(0)"
          class="redirect-icon-secondary text-white redirect-link d-lg-none position-relative fs-12">ACT Support
          Program</a>
      </div>
    </nav>
  </header>
  <main>
    <section class="banner position-relative">
      <div class="container text-white position-relative">
        <h3 class="text-yellow text-uppercase">Introducing</h3>
        <h1 class="text-white">ALBRIOZA<sup>TM</sup>: Demonstrated to slow the loss of function in ALS<sup>1†</sup></h1>
        <p class="font-wight-bold pl-lg-1 pr-lg-4 mb-lg-3">ALBRIOZA ± SOC significantly slowed disease progression vs.
          placebo ± SOC over 24 weeks (as measured by rate
          of decline in ALSFRS-R; P=0.03).<sup>1†</sup></p>
        <div class="row row-cols-1 row-cols-md-2">
          <div class="col pr-lg-0">
            <div class="card card-secondary card-one">
              <h5 class="font-weight-bold text-center mb-0">MEAN ALSFRS-R SCORE WAS</h5>
              <p class="text-green fs-40 fs-md-65 pt-md-18 d-flex flex-md-column align-items-center mb-0">
                <span>2.32</span>
                <span class="text-uppercase fs-14 points-higher line-height-17">points higher <br
                    class="d-block d-md-none">with <br class="d-none d-md-block">ALBRIOZA <span
                    class="d-none d-md-inline">± SOC <br class="d-none d-md-block">vs. placebo ± SOC</span>
                </span>
              </p>
              <!-- this line hides on medium screen -->
              <p class="text-green text-uppercase d-block d-md-none fs-14 line-height-17 mb-0">± SOC vs.
                placebo ± SOC</p>
              <p class="fs-12 line-height-18 text-center after-24-weeks mb-0">after 24 weeks of treatment<br
                  class="d-none d-md-block">
                (P=0.03).1<sup>†‡</sup></p>
              <button class="btn btn-secondary position-absolute">Discover the data</button>
            </div>
          </div>
          <div class="col pr-lg-0">
            <div class="card card-secondary card-two text-center">
              <h5 class="font-weight-bold">A FLEXIBLE ORAL <br>SUSPENSION</h5>
              <p>that can be <br class="d-none d-md-block">administered <br>by mouth or <br
                  class="d-none d-md-block">feeding tube1</p>
              <button class="btn btn-secondary position-absolute">LEARN ABOUT DOSING</button>
            </div>
          </div>
        </div>
        <div class="about-albrioza d-none d-lg-block">
          <p class="d-none d-lg-block mb-2">ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) is indicated for the
            treatment of patients with
            amyotrophic lateral sclerosis (ALS).</p>
          <p>ALBRIOZA has been issued marketing authorization with conditions, pending the results of trials to verify
            its
            clinical benefit. Patients should be advised of the nature of the authorization. For further information for
            ALBRIOZA, please refer to Health Canada’s Notice of Compliance with conditions - drug products web site:
            <a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions.html"
              class="text-white">https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions.html</a>
          </p>
        </div>
      </div>
      <div class="enroll-your-patients border-top-0">
        <a href="javascript:void(0)" class="text-white text-decoration-none">Enroll your Patients</a>
      </div>
    </section>
    <section class="als-treatment-plan">
      <div class="container position-relative">
        <div class="card bg-white border-bottom-0 card-primary">
          <h2 class="text-uppercase font-weight-bold text-center">A new therapy for your foundational ALS treatment
            plan</h2>
          <div class="row">
            <div class="col-lg-4 col-one">
              <div class="card border-0">
                <img src="content/images/content-images/functional-benefits.png" class="card-img-top rounded-0"
                  alt="Proven to provide functional benefits">
                <div class="card-body">
                  <h5 class="font-wight-bold text-center">PROVEN TO PROVIDE <br>FUNCTIONAL BENEFITS</h5>
                  <p class="text-left mb-0">In the CENTAUR trial, ALBRIOZA ± SOC significantly slowed disease
                    progression vs.
                    placebo ± SOC over
                    24 weeks (as measured by rate of decline in ALSFRS-R; P=0.03).1<sup>†‡</sup></p>
                </div>
                <div class="card-footer border-0 bg-transparent p-0 text-center">
                  <a href="javascript:void(0)" class="btn btn-primary">EXPLORE EFFICACY</a>
                </div>
              </div>
            </div>
            <div class="col-lg-4 col-two">
              <div class="card border-0">
                <img src="content/images/content-images/safety-profile.png" class="card-img-top rounded-0"
                  alt="Proven to provide functional benefits">
                <div class="card-body">
                  <h5 class="font-wight-bold text-center">DEMONSTRATED <br>SAFETY PROFILE</h5>
                  <p class="text-left mb-3 mb-lg-0">ALBRIOZA was generally well-tolerated in the pivotal clinical trial.
                    The most
                    common AEs were mainly
                    gastrointestinal-related and occurred most often during the first
                    3 weeks of therapy.1§</p>
                </div>
                <div class="card-footer border-0 bg-transparent p-0 text-center">
                  <a href="javascript:void(0)" class="btn btn-primary">SEE SAFETY PROFILE</a>
                </div>
              </div>
            </div>
            <div class="col-lg-4 col-three">
              <div class="card border-0">
                <img src="content/images/content-images/personalized-support.png" class="card-img-top rounded-0"
                  alt="Personalized support">
                <div class="card-body">
                  <h5 class="font-wight-bold text-center">PERSONALIZED <br>SUPPORT</h5>
                  <p class="text-left mb-0">The Amylyx Care Team (ACT)<sup>TM</sup> provides
                    resources and services to support the care of people with ALS
                    as they start and continue on ALBRIOZA.</p>
                </div>
                <div class="card-footer border-0 bg-transparent p-0 text-center">
                  <a href="javascript:void(0)" class="btn btn-primary learn-more-about-act">LEARN MORE ABOUT ACT</a>
                </div>
              </div>
            </div>
          </div>
          <div class="inner-container text-blue-300">
            <p class="small-text">
              <sup>†</sup>The efficacy of ALBRIOZA was assessed in a 24-week, multicenter, randomized, double-blind,
              placebo-controlled, parallel-group study of patients with familial or sporadic ALS. 137 patients were
              randomized 2:1 to receive ALBRIOZA or placebo. The primary efficacy endpoint was a comparison of the rate
              (slope) of reduction in total scores between ALBRIOZA plus SOC vs. SOC alone from baseline to Week 24 in
              the mITT population.1
            </p>
            <p class="small-text">
              <sup>‡</sup>The average baseline ALSFRS-R total score was 35.7 (5.78) in the ALBRIOZA treatment group and
              36.7
              (5.08) in the placebo group.1 <br>§ The most common AEs (≥10%) observed in the ALBRIOZA group were diarrhea
              (18%) and abdominal pain (10%).<sup>1</sup><br>
              AE: adverse event; ALS: amyotrophic lateral sclerosis; ALSFRS-R: ALS Functional Rating Scale-Revised; SOC:
              standard of care therapies.
            </p>
            <div class="text-center border-t-b-botted">
              <h3 class="font-weight-bold fs-22 line-height-36">Establishing clear treatment expectations <br
                  class="d-none d-md-block d-lg-none">with your
                patients can be important</h3>
              <button class="btn btn-secondary">LEARN MORE</button>
            </div>
            <h3>Get Connected</h3>
            <p class="mb-4 mb-lg-0 pr-3 pr-md-0">Fill out the form below to stay informed and receive the latest information on
              ALBRIOZA.</p>
            <p class="fs-14 mb-4 mb-lg-19">* Required fields</p>
            <form class="needs-validation" autocomplete="off" novalidate>
              <div class="form-row">
                <div class="col-md-6 mb-24 pr-md-20 mb-lg-18">
                  <label for="validationCustom01" class="mb-1">First Name*</label>
                  <input type="text" class="form-control" id="validationCustom01" required>
                  <div class="invalid-feedback">
                    Please enter first name
                  </div>
                </div>
                <div class="col-md-6 mb-24 pl-md-20 mb-lg-18">
                  <label for="validationCustom02" class="mb-1">Last Name*</label>
                  <input type="text" class="form-control" id="validationCustom02" required>
                  <div class="invalid-feedback">
                    Please enter last name
                  </div>
                </div>
              </div>
              <div class="form-row">
                <div class="col-md-6 pr-md-20 mb-24 mt-1">
                  <label for="validationCustom03" class="mb-1">Email*</label>
                  <input type="email" class="form-control" id="validationCustom03" required>
                  <div class="invalid-feedback">
                    Please enter valid email
                  </div>
                </div>
                <div class="col-md-6 pl-md-20 mb-24 mt-1 mb-lg-18">
                  <label for="validationCustom05" class="mb-1">Phone</label>
                  <input type="text" class="form-control">
                </div>
              </div>
              <div class="form-row">
                <div class="col-md-6 pr-md-20 mb-3">
                  <label for="Place of Practice" class="mb-1 d-block">Place of Practice</label>
                  <select class="custom-select" name="state" required>
                    <option selected disabled value=""></option>
                    <option value="Alberta">Alberta</option>
                    <option value="British Columbia">British Columbia</option>
                    <option value="Manitoba">Manitoba</option>
                    <option value="New Brunswic">New Brunswick</option>
                    <option value="Newfoundland and Labrador">Newfoundland and Labrador</option>
                    <option value="Northwest Territories">Northwest Territories</option>
                    <option value="Nova Scotia">Nova Scotia</option>
                    <option value="Nunavut">Nunavut</option>
                    <option value="Ontario">Ontario</option>
                    <option value="Prince Edward Island">Prince Edward Island</option>
                    <option value="Quebec">Quebec</option>
                    <option value="Saskatchewan">Saskatchewan</option>
                    <option value="Yukon">Yukon</option>
                  </select>
                  <div class="invalid-feedback">
                    Please select a valid place.
                  </div>
                </div>
              </div>
              <div class="form-row mt-3 mt-lg-3">
                <div class="col-md-4 mb-4">
                  <p class="font-weight-bold mb-12">Area of Interest</p>
                  <div class="form-check">
                    <input class="form-check-input" type="checkbox" value="Efficacy & Safety" id="efficacy-and-safety">
                    <label class="form-check-label" for="efficacy-and-safety">
                      Efficacy & Safety
                    </label>
                  </div>
                </div>
                <div class="col-md-4 mb-4 pt-md-32 pl-md-20">
                  <div class="form-check">
                    <input class="form-check-input" type="checkbox" value="Dosing Information" id="dosing-information">
                    <label class="form-check-label" for="dosing-information">
                      Dosing Information
                    </label>
                  </div>
                </div>
              </div>
              <div class="form-row">
                <div class="col-md-4 mb-4">
                  <div class="form-check">
                    <input class="form-check-input" type="checkbox" value="Patient Support Program"
                      id="patient-support-program">
                    <label class="form-check-label" for="patient-support-program">
                      Patient Support Program
                    </label>
                  </div>
                </div>
                <div class="col-md-4 mb-4 pl-md-20">
                  <div class="form-check">
                    <input class="form-check-input" type="checkbox" value="Medical Information"
                      id="medical-information">
                    <label class="form-check-label" for="medical-information">
                      Medical Information
                    </label>
                  </div>
                </div>
              </div>
              <div class="form-group mt-3">
                <div class="form-check d-block">
                  <input class="form-check-input" type="checkbox" value="confirmed" id="confirmation" required>
                  <label class="form-check-label" for="confirmation">
                    Please confirm that you are a Canadian Healthcare Professional.*
                  </label>
                  <div class="invalid-feedback">
                    You must confirm before submitting.
                  </div>
                </div>
              </div>
              <div class="form-captcha">
                <label class="d-block font-weight-bold">Please verify your request*</label>
                <img src="./content/images/content-images/re-captcha.png" alt="recaptcha" class="img-fluid" />
              </div>
              <div class="text-center">
                <button class="btn btn-primary" type="submit">Submit</button>
              </div>
              <p class="fs-14 fs-lg-18 line-height-17 line-height-lg-24">By clicking SUBMIT, you confirm that you have
                read Amylyx’s <a href="javascript:void(0)" class="text-blue-100 text-decoration-underline"><u>Privacy
                    Policy</u></a> and that you agree to receive
                the electronic communications from Amylyx that you’ve selected. You can withdraw your consent at any
                time.
              </p>
            </form>
          </div>
        </div>
      </div>
    </section>
    <section class="bg-gray-200">
      <div class="container border-t-botted pt-5 pb-3">
        <p><strong>Reference: 1.</strong> ALBRIOZA Product Monograph. Amylyx Pharmaceuticals Inc. June 1, 2022.</p>
      </div>
    </section>
  </main>
  <footer class="text-white mt-0">
    <div class="container">
      <div class="row">
        <div class="col-lg-7 order-2 order-lg-1 col-one">
          <img src="./content/images/style-images/amylyx-logo-footer.png" alt="logo" />
          <p class="text-left">©2022 Amylyx Pharmaceuticals, Inc. All Rights Reserved. AMYLYX®, the AMYLYX® logo,
            ALBRIOZATM, the
            ALBRIOZATM logo, AMYLYX CARE TEAM (ACT)TM, and the AMYLYX CARE TEAM (ACT)TM logo are trademarks of Amylyx
            Pharmaceuticals, Inc. PM-00133 10/22
            This site is intended for Canadian Healthcare Professionals. </p>
        </div>
        <div class="col-lg-5 order-1 order-lg-2 col-two">
          <p class="mb-2">Get patients started today</p>
          <a href="javascript:void(0)" class="btn btn-secondary download-icon">Download ENROLLMENT Form</a>
          <div class="d-flex justify-content-center justify-content-lg-start footer-links">
            <a href="javascript:void(0)" class="pl-0">Privacy Policy</a>
            <a href="javascript:void(0)">Terms of Use</a>
            <a href="javascript:void(0)">Contact Us</a>
            <a href="javascript:void(0)" class="pr-0 border-right-0">Site Map</a>
          </div>
        </div>
      </div>
    </div>
  </footer>
  <!-- popup modal -->
  <!-- Modal -->
  <div class="modal fade" id="important-safety-info" tabindex="-1" aria-labelledby="importantSafetyInfo"
    aria-hidden="true">
    <div class="modal-dialog modal-xl">
      <div class="modal-content">
        <div class="modal-header border-bottom-0 p-0">
          <button type="button" class="close" data-dismiss="modal" aria-label="Close">
            <span aria-hidden="true">&times;</span>
          </button>
        </div>
        <div class="modal-body">
          <div class="modal-about-albrioza">
            <p>ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) is indicated for the treatment of patients with
              amyotrophic lateral sclerosis (ALS).
            </p>
            <p>
              ALBRIOZA has been issued marketing authorization with conditions, pending the results of trials
              to verify its clinical benefit. Patients should be advised of the nature of the authorization. For further
              information for ALBRIOZA, please refer to Health Canada’s Notice of Compliance with conditions -
              drug products web site: <a
                href="https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions.html"
                class="text-blue-100"><u>https://www.canada.ca/en/health-canada/services/drugs-health-products/
                  drug-products/notice-compliance/conditions.html</u></a>
            </p>
          </div>
          <div class="list-content-wrapper">
            <p>ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) is indicated for the treatment of patients with
              amyotrophic lateral sclerosis (ALS).</p>

            <p>Please consult the <a href="javascript:void(0)" class="text-blue-100"><u>ALBRIOZA Product
                  Monograph</u></a> or <a href="javascript:void(0)" class="text-blue-100"><u>click here</u></a> for more
              information on:</p>
            <ul class="list">
              <li>Contraindications in patients with hypersensitivity to this drug, bile salts, or to any ingredient in
                the formulation, including any non-medicinal ingredients, or component of the container; pregnancy; and
                breastfeeding </li>
              <li>Relevant warnings and precautions regarding sodium content and patients with congestive heart failure,
                renal insufficiency, or other conditions associated with sodium retention with edema; dextrates
                content; sorbitol content; potential for mutagenicity and carcinogenicity; cardiac events and
                electrocardiogram (EKG) abnormalities; patients with hepatic insufficiency; patients with enterohepatic
                circulation disorders, pancreatic disorders or intestinal diseases which may alter the concentration of
                bile acids and affect ursodoxicoltaurine levels, or partial biliary obstruction; neurotoxicity; patients
                with renal insufficiency; and pregnant or breastfeeding women</li>
              <li>Conditions of clinical use, adverse reactions, drug interactions, and dosing information
              </li>
            </ul>
            <p>
              The <a href="javascript:void(0)" class="text-blue-100"><u>Product Monograph</u></a> is also available by calling us at 1-877-374-1208.
            </p>
          </div>
        </div>
      </div>
    </div>
  </div>
  <!-- / popup modal -->
  <!-- jquery cdn -->
  <script src="./content/scripts/jquery.min.js"></script>
  <!-- / jquery cdn -->
  <script src="./content/scripts/script.min.js"></script>
  <link href="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/css/select2.min.css" rel="stylesheet" />
  <script src="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/js/select2.min.js"></script>
  <script src="./content/scripts/bootstrap.min.js"></script>
</body>

</html>